USPTO serial 99703309
Reviewed by CopyMark Law Group
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: September 22, 2026
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
The USPTO examiner found no conflicting marks, which is a positive outcome, but requires a formal disclaimer for the descriptive word 'TRIAL' in your trademark.
Leap21 LLC
Tampa, FL, US
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SAAS) services featuring software for managing clinical trials, clinical trial data analytics, and clinical trial enrollment simulation | ACTIVE | — |
| Date | Code | Event |
|---|---|---|
| Jun 22, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jun 22, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Jun 22, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jun 22, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Mar 15, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Mar 15, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 15, 2026 | NWAP | NEW APPLICATION ENTERED |